Suggestions
Matthew Robson
Chief Scientific Officer at Novartis Pharma KK
Matthew Robson is a highly accomplished professional with a strong background in the pharmaceutical and medical sectors. He studied at Repton School and obtained a MB ChB in Medicine from the University of Bristol. Matthew has held various leadership positions at renowned organizations, including Novartis Pharma KK where he currently serves as the Chief Scientific Officer. Previously, he was the Global Head Medical Affairs for the Cell & Gene Therapies Unit at Novartis. Prior to that, he held executive roles such as Vice President in Hematology and CART in the US Clinical Development and Medical Affairs department at Novartis. Matthew also has experience working at Bristol-Myers Squibb as Vice President in Global Clinical Research specializing in Immuno-Oncology.
